Proteomika Overview

Founded 2002
Status Acquired/​Merged
Employees 5
Latest Deal Type M&A

Proteomika General Information


Provider of biomarkers designed for non-invasive diagnosis of complex diseases. The company's biomarkers are diagnostic assays that offers individualized optimization of treatment regimes by measuring drug response, such as drug bioavailability and immunogenicity.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Parque Tecnológico de Bizkaia 504
  • 48160 Derio
  • Spain
+34 944 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Proteomika Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jan-2015 Completed Generating Revenue
1. Seed Round 10-Apr-2004 Completed Startup

Proteomika Executive Team (3)

Name Title Board Seat Contact Info
Laureano Simón Ph.D Chief Executive Officer
Antonio Martínez Ph.D Chief Operating Officer
Simon Cruz Ph.D Chief Scientific Officer

Proteomika Former Investors (1)

To view Proteomika‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bizkaia Seed Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial